New antipsychotic medications: strategies for evaluation and selected findings

Schizophrenia Research
N R Schooler

Abstract

The unprecedented level of activity in the development of new antipsychotic medications can be traced to the 1989 approval of clozapine by the US Food and Drug Administration for treatment of refractory schizophrenia. This has encouraged the development of other new agents that share some of clozapine's receptor binding characteristics. A wide range of clinical trial designs are being used during the development of new antipsychotic medications. This article describes both basic designs and more innovative ones: flexible-dose designs that include placebo and conventional neuroleptic agents as controls; fixed-dose designs with multiple doses of experimental medication; and fixed-dose designs with multiple doses of the experimental and comparator medication. The strengths and weaknesses of each are identified. The need for long-term maintenance studies of newer agents is emphasized because psychotic disorders in general, and schizophrenia in particular, are chronic relapsing illnesses. The current status of four newer antipsychotic medications is considered: clozapine, risperidone, olanzapine, and sertindole. The importance of direct comparison among the newer antipsychotic medications in both short- and long-term trials is highl...Continue Reading

References

Jan 1, 1991·Schizophrenia Bulletin·N R Schooler
Aug 1, 1990·Hospital & Community Psychiatry·H Y MeltzerL F Ramirez
Jun 1, 1987·Archives of General Psychiatry·S R MarderP R May
Sep 11, 1971·British Medical Journal·J P Leff, J K Wing
Jan 1, 1966·Psychopharmacologia·S C GoldbergM M Kayce
Jul 15, 1993·The New England Journal of Medicine·J M AlvirJ A Schaaf
Apr 1, 1996·Journal of Clinical Psychopharmacology·D RobinsonG Lerner
Jan 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·G BondolfiH Dufour
Feb 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C M BeasleyS Hamilton
Mar 1, 1996·Psychopharmacology·J Gerlach, D E Casey

❮ Previous
Next ❯

Citations

Nov 13, 2012·The Psychiatric Quarterly·J C HoblynUNKNOWN CSP 555 Investigator Group
Nov 2, 1999·The Australian and New Zealand Journal of Psychiatry·L R DrewK M Griffiths
May 5, 2000·The Cochrane Database of Systematic Reviews·A TuunainenS M Gilbody

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here